Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment

Por Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O’Connor, Mark J., Lukas, Jiri, Bartek, Jiri
Publicado em 2012

Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837–50

Por Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O’Connor, Mark J., Lukas, Jiri, Bartek, Jiri
Publicado em 2013

Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer‐predisposing gene

Por Bartkova, Jirina, Tommiska, Johanna, Oplustilova, Lenka, Aaltonen, Kirsimari, Tamminen, Anitta, Heikkinen, Tuomas, Mistrik, Martin, Aittomäki, Kristiina, Blomqvist, Carl, Heikkilä, Päivi, Lukas, Jiri, Nevanlinna, Heli, Bartek, Jiri
Publicado no Mol Oncol (2008)